Free tool
Diagnostics stocks
We cover 71 companies grouped under the Diagnostics theme. The median market value in the group is $536.97M. Across the group, the median move over the past trading day is +0.43%. 59% of the 70 with a 200-day average trade above it. Price change over the past year runs from −45.8% to +107.9% across the middle 80 percent of the group, with a median of −3.3%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
71 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.24% |
| 0KSX.L | Quest Diagnostics Incorporated | $27.60B | Large cap | +36.94% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +23.25% |
| 0JSY.L | Labcorp Holdings Inc. | $27.37B | Large cap | +20.97% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% |
| GH | Guardant Health, Inc. | $21.90B | Large cap | +166.52% |
| ERF.PA | Eurofins Scientific SE | $14.91B | Large cap | +13.76% |
| ESF0.DE | Eurofins Scientific SE | $14.63B | Large cap | +11.02% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −9.45% |
| BIM.PA | bioMérieux S.A. | $10.40B | Large cap | −37.52% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% |
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% |
| ALQ.AX | ALS Limited | $8.23B | Mid cap | +23.49% |
| 6869.T | Sysmex Corporation | $7.42B | Mid cap | +5.65% |
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% |
| SHL.AX | Sonic Healthcare Limited | $7.20B | Mid cap | −11.60% |
| BLLN | BillionToOne, Inc. | $4.72B | Mid cap | −8.14% |
| ADPT | Adaptive Biotechnologies Corporation | $4.19B | Mid cap | +107.18% |
| GRAL | GRAIL, Inc. | $3.69B | Mid cap | +150.69% |
| VCYT | Veracyte, Inc. Common Stock | $3.54B | Mid cap | +49.04% |
| CDNA | CareDx, Inc. | $2.63B | Mid cap | +298.43% |
| WGS | GeneDx Holdings Corp. | $2.61B | Mid cap | −28.28% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +107.86% |
| NEO | NeoGenomics, Inc. | $2.19B | Mid cap | +160.31% |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% |
| PSNL | Personalis, Inc. | $1.84B | Small cap | +267.02% |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.53% |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +11.45% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +7.19% |
| QDEL | QuidelOrtho Corporation | $1.03B | Small cap | −45.57% |
| CSTL | Castle Biosciences, Inc. | $1.02B | Small cap | +70.15% |
| 4694.T | BML, Inc. | $862.01M | Small cap | +7.64% |
| IDX.AX | Integral Diagnostics Limited | $638.89M | Small cap | −17.78% |
| DASA3.SA | Diagnósticos da América S.A. | $636.08M | Small cap | +111.29% |
| FLGT | Fulgent Genetics, Inc. | $548.93M | Small cap | −7.34% |
| 137310.KS | SD Biosensor, Inc. | $536.97M | Small cap | −36.08% |
| 4549.T | Eiken Chemical Co., Ltd. | $486.14M | Small cap | −2.85% |
| CEVI.ST | CellaVision AB (publ) | $413.78M | Small cap | −3.32% |
| ACL.AX | Australian Clinical Labs Limited | $386.24M | Small cap | +12.06% |
| VOX.WA | Voxel S.A. | $382.56M | Small cap | −20.15% |
| NIOX.L | NIOX Group Plc | $382.51M | Small cap | −6.05% |
| 0K3W.L | Myriad Genetics, Inc. | $370.48M | Small cap | −46.71% |
| N3B.F | Anbio Biotechnology | $356.84M | Small cap | −86.59% |
| NNNN | Anbio Biotechnology | $343.67M | Small cap | −84.06% |
| 0KCC.L | Insight Molecular Diagnostics Inc. | $339.65M | Small cap | +80.26% |
| 197A.T | TAUNS LABORATORIES INC. | $337.20M | Small cap | −11.01% |
| YDES | YD Bio Ltd | $331.49M | Small cap | −64.97% |
| SBS.DE | Stratec SE | $324.34M | Small cap | −16.29% |
| IDHC.L | Integrated Diagnostics Holdings plc | $317.40M | Small cap | +20.85% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +186.48% |
| MYGN | Myriad Genetics, Inc. | $291.73M | Small cap | −45.84% |
| 0RAR.L | Stratec SE | $275.63M | Small cap | −13.37% |
| OSUR | OraSure Technologies, Inc. | $260.70M | Small cap | +20.38% |
| ALERS.PA | Eurobio Scientific Société anonyme | $232.78M | Small cap | −18.97% |
| HLS.AX | Healius Limited | $224.62M | Small cap | −55.00% |
| 4595.T | Mizuho Medy Co.,Ltd. | $207.18M | Small cap | +13.41% |
| LUCD | Lucid Diagnostics Inc. | $190.95M | Small cap | −12.93% |
| XGN | Exagen Inc. | $184.11M | Small cap | −22.84% |
| PEB.AX | Pacific Edge Limited | $182.42M | Small cap | +64.00% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $179.10M | Small cap | +21.25% |
| S2B.WA | Syn2bio S.A. | $149.26M | Small cap | +81.79% |
| 0ELV.L | Guerbet SA | $146.82M | Small cap | −62.12% |
| IMDX | Insight Molecular Diagnostics Inc. | $145.30M | Small cap | +78.31% |
| EKF.L | EKF Diagnostics Holdings plc | $144.58M | Small cap | −13.90% |
| BVXP.L | Bioventix PLC | $124.78M | Small cap | −30.64% |
| PCSC | Perceptive Capital Solutions Corp | $123.25M | Small cap | +13.16% |
| SCP.WA | Scope Fluidics S.A. | $120.56M | Small cap | −9.34% |
| S84.F | Scope Fluidics S.A. | $119.81M | Small cap | −9.76% |
| QUCY | Quantum Cyber N.V. | $110.13M | Small cap | −20.93% |
| BNR | Burning Rock Biotech Limited | $108.84M | Small cap | +13.95% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $106.02M | Small cap | −60.27% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.